Stempeutics Research Private Limited (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Stempeutics Research Private Limited

An innovative life science company focused on developing & commercializing novel therapeutics based on adult stem cells

Founded 2006 India

India 48 employees Biotechnology, Health Care +1

Stempeutics Research Private Limited is a Bangalore-based innovative life science company focused on developing and commercializing novel therapeutics based on adult stem cells. The company specializes in regenerative medicine, with a patented stem-cell therapy platform technology that targets the treatment of cardiovascular, immune-mediated, and degenerative diseases. Stempeutics has achieved a significant milestone with its flagship product, Stempeucel®, receiving market authorization to treat Critical Limb Ischemia (CLI) – a major unmet medical need in India. Notably, Stempeucel® is the FIRST innovative cell therapy-based product to obtain marketing approval in India and globally. The Indian licensee, CIPLA, has begun nationwide commercialization. Additionally, the company has a product in the Phase 3 stage covering Diabetic Foot Ulcer and is conducting Phase 2 trials in Perianal fistula due to Crohn’s disease. Stempeucel® is supported by strong patent protection with 20 patents granted, including in the US, Europe, and Japan. It has also been classified as an Advanced Therapy Medicinal Product (ATMP) and designated as an Orphan Drug by the European Medicines Agency. In addition to its therapeutic portfolio, Stempeutics has introduced the Stempeucare® range of cosmetics, developed from stem cell-derived Growth Factors/Cytokines combination for various cosmetic and derma applications. The first product, Cutisera™, under the Stempeucare® brand, has already entered the market, with other products like Trichosera™ for Hair application and Optisera™ for under-eye application ready for marketing. With a robust pipeline in cell and gene therapy products spanning health and personal care segments, Stempeutics aims to revolutionize the cell & gene therapy space with its India First, Global Next approach. Established in 2006, the company operates within the biotechnology, healthcare, and pharmaceutical industries. While no specific headquarters or recent investment details are available, Stempeutics' pioneering work in advanced therapy products and its innovative approach to addressing unmet medical needs position it as a compelling player in the rapidly evolving regenerative medicine landscape.

FAQ About Stempeutics Research Private Limited

An innovative life science company focused on developing & commercializing novel therapeutics based on adult stem cells

Stempeutics Research Private Limited was founded in 2006.

Stempeutics Research Private Limited is headquartered in India.

Stempeutics Research Private Limited operates in the following industries: Biotechnology, Health Care, Pharmaceutical.

Stempeutics Research Private Limited has approximately 48 employees.

Top alternatives and competitors to Stempeutics Research Private Limited include Stem Cell Cure India, Orchard Therapeutics - U.S., Cell BioEngines, Inc, Rinati Skin, LLC, Neuralstem, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Stempeutics Research Private Limited and Stem Cell Cure India are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Stempeutics Research Private Limited

General Information

Track Stempeutics Research Private Limited

Discover More

About Stempeutics Research Private Limited

Stempeutics Research Private Limited Alternatives & Competitors

FAQ About Stempeutics Research Private Limited

Don't just browse. Track.